ICHNOS SCIENCES
DEAD

Serial Number

88449114

Owner

Glenmark Pharmaceuticals Limited

Attorney

Monica Riva Talley

Filing Date

May 28, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ICHNOS SCIENCES Trademark

Serial Number: 88449114

ICHNOS SCIENCES is a trademark filed by Glenmark Pharmaceuticals Limited on May 28, 2019. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Glenmark Pharmaceuticals Limited (11 trademarks)

2/B Mahalaxmi Chamber 22
Mumbai , IN

Entity Type: 03

ICHNOS SCIENCES SA (9 trademarks)

CHEMIN DE LA COMBETA 5 10166 , CH

Entity Type: 33

Trademark Details

Filing Date

May 28, 2019

Registration Date

Not Registered

Published for Opposition

March 3, 2020

Goods & Services

Educational services, namely, providing workshops and seminars in the fields of cancer treatment, oncology, immunology and pain management; Publication of journals featuring research articles and clinical trials for pharmaceutical preparations; education services, namely, conducting online instruction and courses in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; training in the use and operation of medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; educational services, namely, providing non-downloadable webinars in the field of health and medical information and distribution of course material in connection therewith; education services, namely, developing, arranging and conducting educational programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; providing training programs and developing training programs relating to the use and operation of medical devices, medical research apparatus and consultation relating thereto; providing online publications, namely, instructional materials in the nature of worksheets and textbooks, featuring study materials in the field of pharmaceutical products, healthcare and medical disease, disorders and related treatments; conducting educational seminars in the fields of healthcare, the use of pharmaceuticals, and medical devices, medical research, surgery, medical science and medicine

Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; medical and pharmaceutical preparations, namely, inhaler preparations for treatment of Chronic obstructive pulmonary disease (COPD); Opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, and for the treatment of inflammatory disorders, and for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical and biological preparations for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; medicated skin care preparations; medicated skin care preparations, namely, gels; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint disease; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; preparation for the relief of pain; preparations for the treatment of asthma; preparations for therapeutic or medical purposes, namely, therapeutic medicated skin preparations for treatment of skin diseases; decongestant nasal sprays

Cosmetic soaps; Skin soaps; shampoos; sunscreen for cosmetic use; perfumery; essential oils; body powder; cosmetics; anti-aging creams; hair lotion; cosmetic skin care preparations; skin creams; skin moisturizing gel; face wash; moisturizing body lotions; and non-medicated mouthwashes

Campaign for patient support program, namely, promoting public awareness for patients with cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases

Licensing of patents, trademarks and intellectual property

Providing information in the field of medicine and health in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical services in the field of oncology, pain management. dermatology, diabetology, respiratory diseases and dietetic advisory services; medical assistance in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; hygiene care for human beings in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical clinic services; dietetic advisory services; disseminating medical information to patients for better lifestyle management to handle the treatment of side effects in the course of treatment of cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases

Medical apparatus and instruments, namely, spirometers; medical devices, namely, inhalers sold empty, nebulizers; medical devices, namely, autoanalysers; chromatographic medical diagnostic apparatus

Scientific research for medical purposes in the field of oncology, pain management, dermatology, diabetology, respiratory diseases, biosimilars; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis, testing in the field of oncology, immunology and pain management; medical research in the fields of oncology, immunology and pain management; clinical research in the fields of oncology, immunology and pain management; scientific research and development; pharmaceutical drug development services; pharmaceutical research and development; research and development for new products for others; chemical, pharmaceutical, nutraceuticals and nutritional science, dermo-cosmetic and biotechnology analysis and research; design and testing for new product development; Diagnostic product testing and analysis, namely, medical research and product research for industrial uses; scientific research in the fields of chemistry, biotechnology and pharmacology; medical and pharmaceutical research services, scientific research services for medical purposes including and not limited to bacteriological research services, biomedical research services, laboratory research services, clinical trial services, pharmacological research services, medical research laboratory services, scientific and technological services and research and design relating thereto

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 30, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 29, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 22, 2022 EXRA
SOU EXTENSION 5 GRANTED
Sep 21, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 21, 2022 AITU
SOU EXTENSION 5 FILED
Sep 8, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Sep 8, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 16, 2022 EXRA
SOU EXTENSION 4 GRANTED
Apr 14, 2022 EX4G
SOU EXTENSION 4 FILED
Apr 14, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 14, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2021 EXRA
SOU EXTENSION 3 GRANTED
Oct 26, 2021 EX3G
SOU EXTENSION 3 FILED
Oct 26, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 26, 2021 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 7, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 7, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 7, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 7, 2021 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2021 EXRA
SOU EXTENSION 2 GRANTED
Apr 27, 2021 EX2G
SOU EXTENSION 2 FILED
Apr 27, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 27, 2021 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 14, 2021 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2020 EXRA
SOU EXTENSION 1 GRANTED
Oct 26, 2020 EX1G
SOU EXTENSION 1 FILED
Oct 26, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 26, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 28, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
ASSIGNED TO LIE
Jan 27, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 24, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 24, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 24, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 24, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 24, 2020 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 14, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Oct 8, 2019 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 19, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 19, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 19, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 19, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 16, 2019 TROA
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Sep 7, 2019 CEPE
ASSIGNED TO LIE
Sep 7, 2019 ALIE
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sep 6, 2019 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Sep 6, 2019 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Sep 6, 2019 CPEA
ASSIGNED TO EXAMINER
Aug 16, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2019 NWOS
NEW APPLICATION ENTERED
May 31, 2019 NWAP